ID
38902
Description
Study ID: 111364 Clinical Study ID: 111364 Study Title: A 28-Day, Polysomnographic and subjective assessment of Vestipitant (15mg/day) for the treatment of Primary Insomnia in adult Outpatients Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00992160 Clinicaltrials.gov Links: https://clinicaltrials.gov/ct2/show/NCT00992160 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Vestipitant, Placebo Trade Name: N/A Study Indication: Primary Insomnia, Sleep Disorders This phase II, placebo-controlled, double-blind trial studies the polysomnographic and subjective effect of the neurokinin (NK1) antagonist vestipitant (15mg/day at bedtime) for the treatment of primary insomnia in adult outpatients over a period of four weeks. The study consists of a clinical Screening Visit (Visit 1), up to 21 days before investigational product/placebo initiation, two screening polysomnographies (Visits 2 and 3), followed by a placebo run-in until Visit 4, at which the subject is randomized to vestipitant or placebo, taken every night for 28 days. On Day 1 and 2 (Visits 4 and 5), polysomnographies are performed. Visit 6 is a safety visit on Day 15. On Day 27 and 28, Visits 7 and 8 are performed, which again include polysomnography studies. Subjects then undergo a 7 to 10 day placebo run-out period and have Day 7 and Day 14 Follow-Up Visit (Visits 9 and 10). This form contains the Study Conclusion, information on the treatment blind and whether a pregnancy has occured during the study. This form is to be completed at the Day 14 Follow-up or if the participant has/was withdrawn from the trial.
Link
https://clinicaltrials.gov/ct2/show/NCT00992160
Keywords
Versions (2)
- 11/12/19 11/12/19 -
- 11/12/19 11/12/19 - Sarah Riepenhausen
Copyright Holder
GlaxoSmithKline
Uploaded on
November 12, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Polysomnographic Assessment of Vestipitant for the Treatment of Primary Insomnia NCT00992160
Study Conclusion, Pregnancy, Treatment Blind
- StudyEvent: ODM
Description
Study Conclusion
Alias
- UMLS CUI-1
- C1707478
- UMLS CUI-2
- C0008976
Description
If the subject completed the study: Date of last contact must match the last scheduled study visit date. If the subject withdrew: Date of decision to withdraw must match the date of decision to withdraw the subject from the study before normal completion. Date of last contact must match the last actual contact with the subject whether or not the contact was a clinic visit. Do not record dates of unsuccessful attempts to contact the subject. Note: An ’actual contact’ is defined as an interaction between the subject and the investigator or investigator’s designee, where the investigator/designee has the opportunity to query the subject about the subject’s status. This would include clinic visits and telephone contacts, but normally would not include mail correspondence or third party reports.
Data type
date
Alias
- UMLS CUI [1]
- C0805839
Description
If yes, complete details
Data type
boolean
Alias
- UMLS CUI [1]
- C0422727
Description
if applicable
Data type
date
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C0679006
- UMLS CUI [1,3]
- C0011008
Description
Adverse Event, please record details on the Non-Serious Adverse Events or Serious Adverse Events forms as appropriate. If Investigator discretion, specify in next question. Select this reason if none of the other primary reasons are appropriate.
Data type
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C1549995
Description
if applicable
Data type
text
Alias
- UMLS CUI [1,1]
- C2348235
- UMLS CUI [1,2]
- C0008961
- UMLS CUI [1,3]
- C0022423
Description
Data owner should check the box when data cleaning is complete
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1706256
- UMLS CUI [1,2]
- C1519316
Description
Office Use 1
Data type
boolean
Alias
- UMLS CUI [1]
- C0442603
Description
Office Use 2
Data type
integer
Alias
- UMLS CUI [1]
- C0442603
Description
Pregnancy Information (female)
Alias
- UMLS CUI-1
- C0032961
- UMLS CUI-2
- C1533716
- UMLS CUI-3
- C0086287
Description
Pregnancy Information (male)
Alias
- UMLS CUI-1
- C0032961
- UMLS CUI-2
- C1533716
- UMLS CUI-3
- C0086582
Description
If Yes, complete the paper Pregnancy Notification form Check "Not Applicable" if female partner not of childbearing potential or no female partner.
Data type
text
Alias
- UMLS CUI [1,1]
- C0919624
- UMLS CUI [1,2]
- C0439659
- UMLS CUI [1,3]
- C0347984
- UMLS CUI [1,4]
- C0008976
Description
Status of Treatment Blind
Alias
- UMLS CUI-1
- C2347038
- UMLS CUI-2
- C0449438
Description
If yes, complete the Adverse Event form and/or Investigational Product forms as appropriate, and fill in the rest of this itemgroup.
Data type
boolean
Alias
- UMLS CUI [1]
- C3897431
Description
if applicable
Data type
datetime
Alias
- UMLS CUI [1,1]
- C3897431
- UMLS CUI [1,2]
- C1264639
Description
if applicable If other, please specify
Data type
text
Alias
- UMLS CUI [1,1]
- C3897431
- UMLS CUI [1,2]
- C0566251
Description
if applicable
Data type
text
Alias
- UMLS CUI [1,1]
- C0566251
- UMLS CUI [1,2]
- C3897431
- UMLS CUI [1,3]
- C2348235
Similar models
Study Conclusion, Pregnancy, Treatment Blind
- StudyEvent: ODM
C2985720 (UMLS CUI [2])
C0679006 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C1549995 (UMLS CUI [1,2])
C0008961 (UMLS CUI [1,2])
C0022423 (UMLS CUI [1,3])
C1519316 (UMLS CUI [1,2])
C1533716 (UMLS CUI-2)
C0086287 (UMLS CUI-3)
C1533716 (UMLS CUI-2)
C0086582 (UMLS CUI-3)
C0439659 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,4])
C1264639 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C3897431 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])